The present study was conducted to determine the preventive efficacy of vitamin C/E complex supplementation for radiotherapy (RT)–induced xerostomia in patients with head and neck cancer.
The trial group (n = 25) received antioxidant supplements (100 IU of vitamin E + 500 mg of vitamin C) twice per day during RT, while the control group (n = 20) received an identical placebo. Pre-RT and 1 and 6 months post-RT, patient-reported xerostomia questionnaires, observer-rated xerostomia score, and salivary scintigraphy were serially obtained to compare xerostomia severity between the 2 groups.
Results
The trial group showed greater improvements in xerostomia questionnaire and score at 6 months post-RT when compared with those at 1 month post-RT (P = .007 and .008, respectively). In contrast, the control group showed no changes between 1 and 6 months post-RT. By salivary scintigraphy, there was no difference in maximal accumulation or ejection fraction between the 2 groups. However, the trial group maintained significantly better oral indices at the prestimulatory (P = .01) and poststimulatory (P = .009) stages at 1 month post-RT, compared with the control group. At the final follow-up, there was no difference in overall survival and disease-free survival between the 2 groups.
Conclusions
Our data suggest that short-term supplementation with an antioxidant vitamin E/C complex exerts a protective effect against RT-induced xerostomia.
CoppesRPVissinkAZeilstraLJKoningsAW. Muscarinic receptor stimulation increases tolerance of rat salivary gland function to radiation damage. Int J Radiat Biol. 1997;72:615-625.
2.
EpsteinJBEmertonSLeNDStevenson-MooreP. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol. 1999;35:132-137.
3.
EisbruchAKimHMTerrellJEMarshLHDawsonLAShipJA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704.
4.
DirixPNuytsSVan den BogaertW. Radiation-induced xerostomia in patients with head-and-neck cancer: a literature review. Cancer. 2006;107:2525-2534.
5.
AnnePRMachtayMRosenthalDI. A phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2007;67:445-452.
6.
Nieuw AmerongenAVVeermanEC. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer. 2003;11:226-231.
7.
BairatiIMeyerFGelinasM. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head-and-neck cancer patients. J Clin Oncol. 2005;23:5805-5813.
8.
HuangTLChienCYTsaiWL. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated by intensity modulated radiotherapy (IMRT) versus non-IMRT [published online June3, 2015]. Head Neck.
9.
GornitskyMShenoudaGSultanemK. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head-and-neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:45-52.
10.
SeikalyHJhaNHarrisJR. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg. 2004;130:956-961.
11.
HakimSGKosmehlHLauerINadrowitzRWedelTSiegP. A comparative study on the protection profile of lidocaine, amifostine, and pilocarpin on the parotid gland during radiotherapy. Cancer Res. 2005;65:10486-10493.
12.
GensheimerMFLiaoJJGardenASLaramoreGEParvathaneniU. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. Radiat Oncol. 2014;9:255.
13.
PimentelMJFilhoMMAraujoMGomesDQDa CostaLJ. Evaluation of radioprotective effect of pilocarpine ingestion on salivary glands. Anticancer Res. 2014;34:1993-1999.
14.
FoxNFXiaoCSoodAJ. Hyperbaric oxygen therapy for the treatment of radiation-induced xerostomia: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120:22-28.
15.
JaguarGCLimaENKowalskiLP. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head-and-neck cancer patients. Radiother Oncol. 2015;115:253-256.
16.
KerrPMyersCLButlerJAlessaMLambertPCookeAL. Prospective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs intensity modulated radiotherapy. J Otolaryngol Head Neck Surg. 2015;44:17.
17.
LakshmanARBabuGSRaoS. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study. J Cancer Res Ther. 2015;11:229-233.
18.
WongRKDeshmukhSWyattG. Acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating radiation-induced xerostomia: results of RTOG 0537 phase 3 study. Int J Radiat Oncol Biol Phys. 2015;92:220-227.
19.
PrasadKNColeWCKumarBChe PrasadK. Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev. 2002;28:79-91.
20.
WeissJFLandauerMR. Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology. 2003;189:1-20.
21.
ZaidiSMBanuN. Antioxidant potential of vitamins A, E and C in modulating oxidative stress in rat brain. Clin Chim Acta. 2004;340:229-233.
22.
RatnamDVAnkolaDDBhardwajVSahanaDKKumarMN. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release. 2006;113:189-207.
23.
SuhailNBilalNKhanHY. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy. J Clin Pharm Ther. 2012;37:22-26.
24.
LawendaBDKellyKMLadasEJSagarSMVickersABlumbergJB. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?J Natl Cancer Inst. 2008;100:773-783.
25.
MeyerFBairatiIFortinA. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head-and-neck cancer patients. Int J Cancer. 2008;122:1679-1683.
26.
YasuedaAUrushimaHItoT. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther. 2016;15:17-39.
27.
PrasadKNColeWCKumarBPrasadKC. Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. J Am Coll Nutr. 2001;20:450S-463S.
28.
LabriolaDLivingstonR. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Williston Park). 1999;13:1003-1008.
29.
SalganikRI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr. 2001;20:464S-472S.
30.
SuganoSTakeyamaIOginoSKenmochiMKanekoT. Effectiveness of formula ophiopogoins in the treatment of xerostomia and pharyngoxerosis. Acta Otolaryngol Suppl. 1996;522:124-129.
31.
BaekCHChungMKChoiJYSoYKSonYIJeongHS. Role of salivary function in patients with globus pharyngeus. Head Neck. 2010;32:244-252.
32.
KohnWGShipJAAtkinsonJCPattonLLFoxPC. Salivary gland 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med. 1992;21:70-74.
33.
MateosJJSetoainXFerreJ. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours. Nucl Med Commun. 2001;22:651-656.
